Biosceptre
Babraham
About Biosceptre
Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from a wide range of malignancies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: biosceptre.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biosceptre-98138 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.